IBIO: מחיר למכירות iBio Inc
iBio, Inc. utilizes AI to develop antibodies, fully outsourcing production and testing to third-party contractors. The historical P/S trend visualizes market expectations, where 45.10 indicates the value of this parameter. Currently, iBio, Inc. has no recurring revenue, relying instead on the success of its developments. Meanwhile, deep integration with global partners optimizes research costs and minimizes operational risks.
פילוחי מדדים ואנליטיקה של חברת iBio Corp (IBIO)
The P/S ratio compares the market capitalization of iBio, Inc. (IBIO) to its generated revenue, determining the cost of each dollar of sales. For a biotech firm facing liquidity shortages and costly AI development, this metric reflects the extent to which investor expectations are inflated relative to actual cash flows. By analyzing the historical P/S values of iBio, Inc. (IBIO), one can identify points of extreme overvaluation or undervaluation of the asset. Long-term consensus requires benchmarking this metric against the rate of capital dilution.
